Skip to main content
Pharma Mar S.A. logo

Pharma Mar S.A. — Investor Relations & Filings

Ticker · PHM ISIN · ES0169501022 LEI · 959800QWKZ45ZQC2AV58 MC Manufacturing
Filings indexed 351 across all filing types
Latest filing 2018-02-28 Annual Report
Country ES Spain
Listing MC PHM

About Pharma Mar S.A.

https://pharmamar.com/en/

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Recent filings

Filing Released Lang Actions
Annual Report 2017
Annual Report Classification · 100% confidence The document is titled 'Cuentas Anuales e Informe de Gestión' (Annual Accounts and Management Report) for Pharma Mar, S.A. for the fiscal year ending December 31, 2017. It contains detailed financial statements, including the Balance Sheet and Profit and Loss account, as well as audit notes. This constitutes a full annual financial report, which corresponds to the 10-K category in the provided schema. FY 2017
2018-02-28 Spanish
Corporate Governance Report - Pharma Mar S.A.
Remuneration Information Classification · 99% confidence The document is explicitly titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Public Limited Companies). It details the remuneration policy for directors for the period 2016-2018, covering fixed and variable components, maximum remuneration amounts, and references specific articles of Spanish corporate law (LSC) related to director compensation disclosure. This content directly matches the definition of a report detailing compensation for top executives and directors, which corresponds to the 'Remuneration Information' category.
2017-02-24 Spanish
Annual Report 2016
Annual Report Classification · 100% confidence The document contains comprehensive financial statements, including balance sheets, income statements, and statements of changes in equity for Pharma Mar, S.A. for the fiscal year ending 31 December 2016. It provides detailed financial data rather than just an announcement or summary. Given the scope and the inclusion of full financial statements for a specific fiscal period, it is classified as an Annual Report (10-K). FY 2016
2017-02-24 Spanish
Corporate Governance Report - Pharma Mar S.A.
Remuneration Information Classification · 98% confidence The document is explicitly titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Corporations). It details the remuneration policy (A. Política de Remuneraciones), components of remuneration (B. Componentes de la retribución), maximum remuneration amounts (C. Importe máximo de la remuneración), and remuneration for executive directors (D. Política de remuneraciones de los consejeros por el desempeño de sus funciones ejecutivas) for the period 2016-2018, referencing specific articles of the Spanish Capital Companies Act (LSC). This content directly corresponds to the definition of a report detailing compensation for top executives and directors, which maps to the 'Remuneration Information' category. Code mapping: Remuneration Information corresponds to DEF 14A, although the document is Spanish, the content focus is remuneration disclosure, which is the primary function of a DEF 14A in the US context, or similar mandatory disclosure in other jurisdictions. Given the provided options, DEF 14A is the closest fit for a detailed report on director compensation.
2016-02-29 Spanish
Audit Report / Information 2015
Audit Report / Information Classification · 98% confidence The document text contains detailed financial statements, specifically the 'Balance' (Balance Sheet) and 'Cuenta de Pérdidas y Ganancias' (Income Statement) for the fiscal years ending December 31, 2015, and December 31, 2014. It also mentions the 'Informe de Auditoría de Cuentas Anuales' (Annual Accounts Audit Report) and 'Informe de Gestión' (Management Report) in the header. Since the document provides the full, detailed financial statements (Balance Sheet and Income Statement) for a full fiscal year, it strongly aligns with the content expected in an Annual Report (10-K equivalent, although this specific document appears to be a Spanish statutory filing). Given the comprehensive nature of the financial data presented, the most appropriate classification is Annual Report (10-K), as it contains the core financial performance data for the year. FY 2015
2016-02-29 Spanish
Audit Report / Information 2014
Audit Report / Information Classification · 99% confidence The document text explicitly contains the title "Informe de auditoría, cuentas anuales al 31 de diciembre de 2014 e informe de gestión del ejercicio 2014" and the section header "INFORME DE AUDITORÍA INDEPENDIENTE DE CUENTAS ANUALES". It details the scope of the audit, the responsibilities of the auditors, and concludes with an "Opinión" regarding the financial statements for the year ended December 31, 2014. Furthermore, it includes the Balance Sheet ("Balance") and Equity and Liabilities section for the years 2014 and 2013. This content strongly indicates a formal Audit Report accompanying the Annual Financial Statements. Since the document is the full report itself (indicated by its large size and detailed financial tables), the most appropriate classification is Audit Report / Information (AR), rather than a mere announcement (RPA). FY 2014
2015-11-02 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.